Works matching IS 20406207 AND DT 2018 AND VI 9 AND IP 1
Results: 2
Experience with ibrutinib for first-line use in patients with chronic lymphocytic leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2018, v. 9, n. 1, p. 3, doi. 10.1177/2040620717741861
- By:
- Publication type:
- Article
New and emerging therapies for acute and chronic graft versus host disease.
- Published in:
- Therapeutic Advances in Hematology, 2018, v. 9, n. 1, p. 21, doi. 10.1177/2040620717741860
- By:
- Publication type:
- Article